RLAY
Relay Therapeutics Inc
17.50$
-1.5%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | -98.8% | -11.3% | -21.1% | -14.9% | -26.1% | -12.9% | -5.8% | -26.5% | -10.7% | -47.3% | +21,078.2% | -100.0% | – | -100.0% | – | – | – | -91.2% | -100.0% | – | -57.1% | -88.3% | – | |
| – | – | – | – | – | -0.2% | +12.5% | -96.3% | +3,257.7% | +47.4% | -2.2% | +15.7% | +1.1% | +17.1% | +10.6% | -4.4% | +29.6% | +6.5% | -7.6% | -9.4% | +11.6% | +11.6% | -16.7% | -15.9% | – | – | +10.4% | -99.1% | -15.9% | – | – | |
| – | – | – | – | – | – | – | – | -136.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -891.7% | – | – | -61.0% | -86.0% | – | |
| – | +23.0% | +11.3% | +22.7% | -3.2% | -0.2% | +12.5% | +28.9% | -2.5% | +449.1% | -73.3% | +15.4% | -0.5% | +17.1% | +10.6% | +0.6% | +23.1% | +6.5% | -7.6% | -4.9% | +6.3% | +11.6% | -16.7% | -11.2% | +8.4% | -13.4% | +6.8% | -18.8% | +27.3% | +8.4% | – | |
| – | +14.4% | +4.1% | -6.2% | +38.9% | +27.2% | +102.1% | +27.1% | -18.1% | +13.2% | +0.1% | -0.3% | +11.6% | +8.7% | -8.0% | -3.7% | +26.5% | +2.8% | -8.1% | -12.6% | +22.6% | +1.7% | -1.9% | -17.4% | +14.9% | -27.4% | -11.3% | +7.4% | -14.9% | +33.2% | – | |
| – | +21.4% | +10.1% | +17.9% | +2.4% | +4.8% | +32.1% | +27.7% | -72.8% | +1,072.2% | -88.3% | -1.7% | -33.3% | +54.0% | +9.5% | -52.5% | +102.4% | -3.3% | -3.8% | +6.0% | -2.0% | -51.2% | +125.3% | +4.1% | +350.3% | -82.7% | -22.1% | +436.2% | +21.0% | +12.4% | – | |
| – | – | – | – | – | – | – | – | -221.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | +44.4% | +70.4% | +99.3% | +103.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | -219.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +6.7% | -5.6% | -14.1% | -18.1% | -36.7% | -46.8% | -45.6% | -23.3% | -18.1% | -13.3% | -632.5% | – | – | – | -882.5% | – | – | – | – | -92.5% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | -219.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | -214.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.